CIRILLO, PLINIO
 Distribuzione geografica
Continente #
NA - Nord America 3.432
EU - Europa 2.041
AS - Asia 1.887
AF - Africa 36
SA - Sud America 11
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 7.409
Nazione #
US - Stati Uniti d'America 3.335
SG - Singapore 845
IT - Italia 716
CN - Cina 523
HK - Hong Kong 441
NL - Olanda 238
FI - Finlandia 221
IE - Irlanda 195
DE - Germania 170
SE - Svezia 139
UA - Ucraina 116
CA - Canada 92
RU - Federazione Russa 86
GB - Regno Unito 55
CI - Costa d'Avorio 35
FR - Francia 33
IN - India 24
BG - Bulgaria 23
VN - Vietnam 23
BR - Brasile 9
CZ - Repubblica Ceca 9
BE - Belgio 8
IR - Iran 8
CH - Svizzera 6
ES - Italia 6
AT - Austria 5
MX - Messico 5
JP - Giappone 4
BH - Bahrain 3
LT - Lituania 3
PL - Polonia 3
RO - Romania 3
TW - Taiwan 3
JO - Giordania 2
KZ - Kazakistan 2
PK - Pakistan 2
SK - Slovacchia (Repubblica Slovacca) 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
BD - Bangladesh 1
EC - Ecuador 1
EU - Europa 1
KE - Kenya 1
KH - Cambogia 1
MK - Macedonia 1
OM - Oman 1
PE - Perù 1
PH - Filippine 1
PT - Portogallo 1
SI - Slovenia 1
SM - San Marino 1
Totale 7.409
Città #
Singapore 689
Chandler 550
Hong Kong 441
Santa Clara 288
Millbury 231
Amsterdam 219
Princeton 203
Nanjing 183
Jacksonville 146
Boston 129
Naples 119
Napoli 108
Wilmington 97
Ottawa 84
Ashburn 81
Des Moines 68
Beijing 63
Nanchang 51
Lawrence 41
Hebei 35
Dublin 32
Seattle 32
Shenyang 32
Norwalk 29
Jiaxing 24
Kronberg 23
Sofia 23
Helsinki 22
Milan 22
Dong Ket 20
Tianjin 20
Rome 19
Falls Church 18
Kunming 18
Boardman 17
Changsha 16
Afragola 15
Augusta 15
Houston 12
Redwood City 12
Ann Arbor 11
Pune 11
Woodbridge 11
Redmond 10
Brno 9
Fairfield 9
Castellammare Di Stabia 8
Dallas 8
Dronten 8
Moscow 8
Toronto 8
Casalnuovo Di Napoli 7
Hangzhou 7
Lappeenranta 7
Torre del Greco 7
Brussels 6
Munich 6
Changchun 5
Chengdu 5
Garbagnate Milanese 5
Guangzhou 5
Indiana 5
Madrid 5
Salerno 5
Shenzhen 5
Aurisina Cave 4
Bari 4
Berlin 4
Bern 4
Catanzaro 4
Council Bluffs 4
Frankfurt am Main 4
Fremont 4
Latham 4
Leawood 4
Los Angeles 4
Mexico City 4
New York 4
San Giuseppe Vesuviano 4
San Mateo 4
Washington 4
Zhengzhou 4
Angri 3
Caivano 3
Casoria 3
Eindhoven 3
Genoa 3
Genova 3
Grumo Nevano 3
Lanzhou 3
London 3
Madinat Hamad 3
Ningbo 3
Nürnberg 3
Pozzuoli 3
Rio de Janeiro 3
San Marcellino 3
Sandston 3
Shanghai 3
Springfield 3
Totale 4.550
Nome #
La leptina induce la produzione di Proteina C-Reattiva in cellule endoteliali coronariche umane. 74
La resistina è un’ adipocitochina in grado di indurre l’ espressione del fattore tissutale da parte di cellule endoteliali prelevate da arterie coronariche umane. 71
Indicazioni alla coronarografia: linee guida 63
Pregnancy-associated plasma protein-A promotes TF procoagulant activity in human endothelial cells by Akt–NF-κB axis 61
Meta-Analysis of Mortality Outcomes and Mitral Regurgitation Evolution in 4,839 Patients Having Transcatheter Aortic Valve Implantation for Severe Aortic Stenosis. 59
ADDED Index or percentage diameter of residual coronary stenosis to risk-stratify patients presenting with STEMI 57
Fructose induces prothrombotic phenotype in human endothelial cells: A new role for “added sugar” in cardio-metabolic risk 53
Estimation of coronary flow reserve by Tc-99m sestamibi imaging in patients with coronary artery disease: comparison with the results of intracoronary Doppler technique 52
Human heart shifts from IGF-1 production to utilization with chronic heart failure 52
Acquired Left Coronary Artery Fistula Draining to Cardiac Vein System after Acute Myocardial Infarction Revealed by CT-Scan. 52
Abluminal-Coated Drug-Eluting Bifurcation-Dedicated Stent for the Treatment of Tibioperoneal Bifurcation 52
Antiplatelet treatment in acute coronary syndrome patients: Real-world data from the START-Antiplatelet Italian Registry 52
Adipokines, Vascular Wall, and Cardiovascular Disease: A Focused Overview of the Role of Adipokines in the Pathophysiology of Cardiovascular Disease. 51
Anorexia nervosa-related cardiopathy in children with physical instability: prevalence, echocardiographic characteristics and reversibility at mid-term follow-up 50
Clinical use of cangrelor: a real world multicenter experience from South Italy Insights from the M.O.Ca. registry 50
Pharmacodynamic effects of cangrelor in elective complex PCI: insights from the POMPEII Registry 49
L'aumento dei livelli di high mobility group box-1 protein (HMGB1) è associato a riduzione dei parametri cardiopolmonari ed ecocardiografici dopo infarto miocardico acuto 49
True double bifurcation lesions: new application of the self-expandable Axxess stent and review of literature with dedicated bifurcation devices 49
Pro-atherothrombotic effects of leptin in human coronary endothelial cells. 48
Impact of chronic kidney disease on platelet aggregation in patients with acute coronary syndrome 48
A New Approach to Percutaneous Coronary Revascularization in Patients Requiring Undeferrable Non Cardiac Surgery. 48
B1-Adrenergic Receptor and Sphingosine-1-Phosphate Receptor 1 (S1PR1) Reciprocal Downregulation Influences Cardiac Hypertrophic Response and Progression to Heart Failure: Protective Role of S1PR1 Cardiac Gene Therapy 48
Diastolic dysfunction reduces stroke volume during daily's life activities in patients with severe aortic stenosis. 46
Bioabsorbable drug-eluting vascular scaffold for the treatment of coronary in-stent restenosis: A two center registry 46
Moderate to severe mitral regurgitation in patients undergoing trancatheter aortic valve replacement: a meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,933 patients 46
Tissue factor binding of activated factor VII triggers smooth muscle cell proliferation via extracellular signal-regulated kinase activation. 45
Long term combination treatment for severe idiopathic pulmonary arterial hypertension 45
La tromboaspirazione: una tecnica emergente 45
Activating stimuli induce platelet microRNA modulation and proteome reorganisation 45
Quantitative detection of inducible ischemia during dobutamine stress by speckle tracking echocardiography: A dream comes true 45
Effects of Carvedilol Versus Metoprolol on Platelet Aggregation in Patients With Acute Coronary Syndrome: The PLATE-BLOCK Study 45
Infiammazione, immunita' umorale e cellulo-mediata in pazienti con sindromi coronariche acute 44
Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction 44
Treatment of residual type A aortic dissection with implantation of the Djumbodis system: is purely endovascular treatment becoming a reality? 44
Pregnancy-Associated Plasma Protein-A and its Role in Cardiovascular Disease. Biology, experimental/clinical evidences and potential therapeutic approaches 44
Autonomic dysfunction is associated with high mobility group box-1 levels in patients after acute myocardial infarction 43
Activated platelets and leucocytes cooperatively stimulate smooth muscle cell proliferation and proto-oncogene expression via release of soluble growth factors. 43
Correction to: Human heart shifts from IGF-1 production to utilization with chronic heart failure (Endocrine, (2019), 65, 3, (714-716), 10.1007/s12020-019-01993-y) 43
Protective role of chronic ubiquinone administration on acute cardiac oxidative stress. 42
Evidence that mitochondrial respiration is a source of potentially toxic oxygen free radicals in intact rabbit hearts subjected to ischemia and reflow. 42
Effects of Hypobaric Hypoxia on Endothelial Function and Adiponectin Levels in Airforce Aviators 42
Facilitation Through Aggrastat or Cangrelor Bolus and Infusion Over PrasugreL: a MUlticenter Randomized Open-label Trial in PatientS with ST-elevation Myocardial InFarction Referred for PrimAry PercutaneouS InTERvention (FABOLUS FASTER) Trial: Design and Rationale : The FABOLUS FASTER Trial 42
Predictors of adherence to composite therapy after acute coronary syndromes 42
Extent of cardiac damage and mortality in patients undergoing transcatheter aortic valve implantation 42
A short burst of oxygen radicals at reflow induces sustained release of oxidized glutathione from postischemic hearts. 41
Nobiletin inhibits oxidized-LDL mediated expression of Tissue Factor in human endothelial cells through inhibition of NF-κB 41
Prevalence and clinical implications of eligibility criteria for prolonged dual antithrombotic therapy in patients with PEGASUS and COMPASS phenotypes: Insights from the START-ANTIPLATELET registry 41
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion 40
Angiographic improvement in STEMI reperfusion: a single centre experience 40
Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are things going well? 40
La Visfatina induce la trascrizione e l' espressione di Tissue Factor attivo in cellule endoteliali coronariche umane in coltura. 40
The adipokine apelin-13 induces expression of prothrombotic tissue factor 40
Role of β2 adrenergic receptors in human atherosclerotic coronary arteries 40
Effetti delle piastrine e dei leucociti sulla proliferazione delle cellule muscolari in vitro: ruolo dei mediatori chimici di derivazione piastrinica. 39
Il fattore VII inattivato esercita una potente attività antitrombotica in un modello sperimentale di trombosi arteriosa ricorrente. 39
Mid-term outcomes after percutaneous interventions in coronary bifurcations 39
Accuracy of global and regional longitudinal strain at peak of dobutamine stress echocardiography to detect significant coronary artery disease 39
Comparative effectiveness of Cangrelor in patients with acute coronary syndrome undergoing percutaneous coronary intervention: an observational investigation from the M.O.Ca. registry 38
A simple method for the isolation, cultivation and characterization of endothelial cells from rabbit coronary circulation. 38
Successful use of the Cardiva Boomerang™ vascular closure device to close a brachial artery puncture site after emergency PTCA. 38
Percutaneous approach to treatment of coronary disease in a patient with uremic cardiomyopathy. 38
Antiplatelet therapy in acute coronary syndromes. Lights and shadows of platelet function tests to guide the best therapeutic approach 38
Local cytokine production in patients with Acute Coronary Syndromes: A look into the eye of the perfect (cytokine) storm 38
Expression of functional tissue factor in activated T-lymphocytes in vitro and in vivo: A possible contribution of immunity to thrombosis? 38
Antiplatelet Therapy for Non–ST-Segment Elevation Myocardial Infarction in Complex “Real” Clinical Scenarios: A Consensus Document of the “Campania NSTEMI Study Group” 38
Effects of colchicine on tissue factor in oxLDL-activated T-lymphocytes 38
Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion. 37
Activated Platelets Stimulate Tissue Factor Expression in Smooth Muscle Cells. 37
Antithrombotic effects of recombinant human, active site-blocked factor VIIa in a rabbit model of recurrent arterial thrombosis. 37
Unrestricted use of endeavour resolute stent in daily clinical practice: a single-centre prospective registry. 37
70 Congresso NAzionale della Societa' Italiana di Cardiologia 37
Low-dose quinacrine reduces vascular restenosis without affecting re-endothelialization 37
Efficacia e sicurezza del nuovo stent a rapida reendotelizzazione Genous in pazienti consecutivi sottoposti ad angioplastica coronarica. 36
A new approach to percutaneous coronary revascoularization in patient requiring undeferrable non-cardiac surgery. 36
Cytokine And Chemokine Expression Profile Within The Coronary Circulation Of Patients With Acute Coronary Syndromes. 36
Multimodality Imaging 36
Exercise training prevents left ventricular remodeling, reduces NT-pro-BNP and improves cardiovascular function in patients with acute myocardial infarction and moderate left ventricular dysfunction 36
Very late bioresorbable scaffold thrombosis and reoccurrence of dissection two years later chronic total occlusion recanalization of the left anterior descending artery 36
Expression of exogenous tissue factor pathway inhibitor in vivo suppresses thrombus formation in injured rabbit carotid arteries. 35
Expansion of Th17 cells and IL-17 production are detectable in selected patients with Acute Coronary Syndromes 35
Dall’ inquadramento clinico al test ergometrico. 35
Abciximab in elderly with acute coronary syndrome invasively treated: effect on outcome. 35
Reactive oxygen species induce a procoagulant state in endothelial cells by inhibiting tissue factor pathway inhibitor 35
Relationship between Pregnancy-associated Plasma Protein-A and tissue factor levels in the coronary circulation of patients with acute coronary syndrome 35
Cangrelor, tirofiban, and chewed or standard prasugrel regimens in patients with st-segment-elevation myocardial infarction: Primary results of the FABOLUS-FASTER trial 35
Vitamin D Inhibits IL-6 Pro-Atherothrombotic Effects in Human Endothelial Cells: A Potential Mechanism for Protection against COVID-19 Infection? 35
Aurintricarbolxylic acid reduces platelet deposition in stenosed and endothelially injured rabbit carotid arteries more effectively than other antiplatelet interventions. 34
Multiple composite grafts (k, ?? or double-Y) in coronary artery surgery: a choice or a necessity? 34
Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study 34
Comparison of the Effect of Dual-Axis Rotational Coronary Angiography Versus Conventional Coronary Angiography on Frequency of Acute Kidney Injury, X-Ray Exposure Time, and Quantity of Contrast Medium Injected 34
Aterosclerosi e instabilizzazione di placca: un processo immuno-mediato 33
The pitfalls of managing thrombosis of an Absorb?-treated bifurcation 33
Meta-Analysis of Effect of Body Mass Index on Outcomes After Transcatheter Aortic Valve Implantation 33
Colchicine reduces platelet aggregation by modulating cytoskeleton rearrangement via inhibition of cofilin and LIM domain kinase 1 33
Endovascular approach for residual Type A aortic dissection 32
72 Congresso Nazionale Societa' Italiana di Cardiologia 32
Quinacrine as a novel drug in the prevention of in-stent restenosis and thrombosis. 32
Induction of tissue factor in the arterial wall during recurrent thrombus formation 31
A monoclonal antibody against tissue factor shortens tissue-plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis. 31
Long term combination treatment for severe idiopathic pulmonary arterial hypertension. 31
Totale 4.189
Categoria #
all - tutte 40.797
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.797


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020270 0 0 0 0 0 0 9 11 10 37 84 119
2020/2021552 11 43 61 42 33 106 24 20 72 20 85 35
2021/20221.177 18 5 15 10 13 79 20 45 244 25 141 562
2022/20231.495 254 100 32 112 188 134 11 114 201 239 81 29
2023/2024971 46 171 109 59 33 73 27 84 38 13 205 113
2024/20251.983 337 517 16 51 180 260 622 0 0 0 0 0
Totale 7.708